Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
NCT07053358
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Neovascular Age-related Macular Degeneration
Interventions
GENETIC:
LX111 Injection
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators
[object Object]